Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KOD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKODKodiak Sciences$4.80+6.9%$3.27$1.92▼$11.60$253.21M2.4344,196 shs615,630 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKODKodiak Sciences+6.90%+16.79%+79.78%-25.00%+35.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKODKodiak Sciences4.0427 of 5 stars3.01.00.04.63.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKODKodiak Sciences 2.00Hold$9.0087.50% UpsideCurrent Analyst Ratings BreakdownLatest 1SN, HE1, KOD, and CUSN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/31/2025KODKodiak SciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.00(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKODKodiak SciencesN/AN/AN/AN/A$5.07 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKODKodiak Sciences-$260.49M-$3.36N/AN/AN/AN/A-84.52%-45.40%5/13/2025 (Estimated)Latest 1SN, HE1, KOD, and CUSN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025KODKodiak Sciences-$0.89N/AN/AN/AN/AN/A3/27/2025Q4 2024KODKodiak Sciences-$0.90-$0.84+$0.06-$0.84N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKODKodiak SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKODKodiak SciencesN/A8.428.42Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKODKodiak Sciences89.06%Insider OwnershipCompanyInsider OwnershipKODKodiak Sciences45.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKODKodiak Sciences9052.75 million28.79 millionOptionable1SN, HE1, KOD, and CUSN HeadlinesRecent News About These CompaniesMore companies announce ARVO 2025 presentationsMay 2 at 10:05 PM | ophthalmologytimes.comKodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular DiseasesMay 1 at 11:43 PM | prnewswire.comTCG Crossover Management LLC Buys 137,380 Shares of Kodiak Sciences Inc. (NASDAQ:KOD)May 1 at 8:03 AM | marketbeat.comNantahala Capital Management LLC Has $2.65 Million Stock Holdings in Kodiak Sciences Inc. (NASDAQ:KOD)April 30 at 8:15 AM | marketbeat.com1,139,527 Shares in Kodiak Sciences Inc. (NASDAQ:KOD) Purchased by Adage Capital Partners GP L.L.C.April 30 at 5:30 AM | marketbeat.comSeismologists monitoring string of Kodiak-area quakesApril 29, 2025 | alaskapublic.orgInvesco Ltd. Acquires 438,635 Shares of Kodiak Sciences Inc. (NASDAQ:KOD)April 28, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Holdings in Kodiak Sciences Inc. (NASDAQ:KOD)April 28, 2025 | marketbeat.comSilverarc Capital Management LLC Purchases 500,000 Shares of Kodiak Sciences Inc. (NASDAQ:KOD)April 24, 2025 | marketbeat.comKodiak Sciences Inc. (NASDAQ:KOD) Short Interest UpdateApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Has $4.59 Million Stake in Kodiak Sciences Inc. (NASDAQ:KOD)April 23, 2025 | marketbeat.comBrokers Issue Forecasts for Kodiak Sciences Q1 EarningsApril 20, 2025 | marketbeat.comSeismic noise tracks sea-ice changesApril 18, 2025 | kodiakdailymirror.comApril 2025's Promising Penny StocksApril 18, 2025 | finance.yahoo.comWhy Kodiak Sciences Inc.’s (KOD) Stock Is Down 10.63%April 8, 2025 | aaii.comHC Wainwright Forecasts Kodiak Sciences Q2 EarningsApril 5, 2025 | marketbeat.comBrokers Set Expectations for Kodiak Sciences Q1 EarningsApril 3, 2025 | marketbeat.comDown -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)April 1, 2025 | zacks.comKODIAK SCIENCES Earnings Results: $KOD Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comKodiak Q4 Loss Narrower Than Expected, Pipeline Development in FocusMarch 28, 2025 | zacks.comKodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial ResultsMarch 28, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over Time1SN, HE1, KOD, and CUSN Company DescriptionsKodiak Sciences NASDAQ:KOD$4.80 +0.31 (+6.90%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$4.75 -0.05 (-1.04%) As of 05/2/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Microsoft Crushes Earnings, What’s Next for MSFT Stock? 3 Biotech Giants Gaining From U.S. Sales and Policy Shifts McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
